Insight Molecular Diagnostics Inc.

IMDX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013
Assets
Cash & Equivalents $7.6M $10.2M $8.0M $257.0K $101.0K
Accounts Receivable
Inventory
Total Current Assets $8.5M $12.7M $10.9M
Property, Plant & Equipment $822.0K $688.0K $576.0K
Goodwill
Intangible Assets (Excl. Goodwill) $746.0K $988.0K $1.2M
Total Assets $10.2M $14.4M $12.7M
Liabilities
Accounts Payable $175.0K $422.0K $285.0K
Total Current Liabilities $4.5M $4.3M $2.3M
Long-Term Debt $1.9M
Total Liabilities $5.8M $4.6M $2.3M
Stockholders' Equity
Retained Earnings $-54.7M $-35.3M $-24.1M
Total Stockholders' Equity $4.4M $9.9M $10.4M $-1.1M $3.6M
← Newer Page 2 of 2 Older →